NCT05143658

Brief Summary

The aim of the study will be to compare the laparoscopic pectopexy (LP) and laparoscopic lateral suspension (LLS) techniques in the management of uterine sparing apical prolapse (POP-Q \>2) at 1 year and yearly up to 2 years.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Dec 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 28, 2021

Completed
1 month until next milestone

First Posted

Study publicly available on registry

December 3, 2021

Completed
3 days until next milestone

Study Start

First participant enrolled

December 6, 2021

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 6, 2021

Completed
2.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

March 4, 2024

Completed
Last Updated

March 5, 2024

Status Verified

March 1, 2024

Enrollment Period

Same day

First QC Date

October 28, 2021

Last Update Submit

March 4, 2024

Conditions

Keywords

pectopexylateral suspensionpelvic organ prolapseuterine sparinglaparoscopy

Outcome Measures

Primary Outcomes (2)

  • Subjective cure rate of prolapse

    Provided by the patient's feeling of the "Absence of a bulge in the vagina"

    [ Time Frame: 12 months after intervention ]

  • Objective success

    Defined as anatomic absence of advanced prolapse at POP-Q sites Ba, C and Bp defined as less than 1 cm individually and as a total

    [ Time Frame: 12 months after intervention ]

Secondary Outcomes (6)

  • Prolapse-related Quality of life

    [ Time Frame: 12 months after intervention ]

  • Failure (%)

    [ Time Frame: 12 months after intervention ]

  • Complications

    [ Time Frame: 12 months after intervention ]

  • Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire (PISQ-12)

    [ Time Frame: 12 months after intervention ]

  • Incontinence Impact Questionnaire (IIQ-7)

    [ Time Frame: 12 months after intervention ]

  • +1 more secondary outcomes

Study Arms (2)

Laparoscopic Lateral Suspension Group (LLS)

ACTIVE COMPARATOR

Anterior and apical prolapse repair via LLS

Procedure: LLS versus LP

Laparoscopic Pectopexy (LP)

EXPERIMENTAL

Anterior and apical prolapse repair via LP

Procedure: LLS versus LP

Interventions

LLS versus LPPROCEDURE

Procedure: Laparoscopic repair of anterior and apical pelvic organ prolapse Surgical correction of anterior and apical pelvic organ prolapse by laparoscopy

Laparoscopic Lateral Suspension Group (LLS)Laparoscopic Pectopexy (LP)

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Women with symptomatic stage 2 or greater (point C -1 or more pelvic organ prolapse quantification POP-Q) apical prolapse

You may not qualify if:

  • Women not eligible for surgery for medical or anesthesiological reasons
  • Inability to comprehend questionnaires
  • Inability to give informed consent
  • Inability to return for a review
  • Prior laparoscopic prolapse repair
  • Prior vaginal mesh prolapse procedure
  • Severe cardiovascular or respiratory disease
  • Women who don't want uterine preserving surgery
  • Pregnancy
  • Age \<18 years, Age \>45 years

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kanuni Sultan Suleyman Training and Research Hospital

Istanbul, 34307, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Pelvic Organ Prolapse

Condition Hierarchy (Ancestors)

ProlapsePathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Officials

  • Ozan Karadeniz, MD

    Kanuni Sultan Suleyman Training and Research Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

October 28, 2021

First Posted

December 3, 2021

Study Start

December 6, 2021

Primary Completion

December 6, 2021

Study Completion

March 4, 2024

Last Updated

March 5, 2024

Record last verified: 2024-03

Locations